Gabrielle Sulzberger - 31 Dec 2023 Form 5 Insider Report for Cerevel Therapeutics Holdings, Inc.

Role
Director
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 Dec 2023
Net transactions value
$0
Form type
5
Filing time
13 Feb 2024, 16:16:33 UTC
Previous filing
19 Dec 2023
Next filing
17 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERE Common Stock Gift $0 +562 +1.2% $0.000000 48,415 29 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.